The American Gastroenterological Association guidelines recognize that long-term or indefinite pharmacotherapy may be appropriate for many patients with obesity, similar to treatment approaches for other chronic conditions like hypertension or diabetes
We make sure members get the right support, the right medication, and real results that last
Scientific American described retatrutide as part of a new class of GLP-1-related drugs that aims at three hormone receptors rather than one
The cost can be high, the side effects can be intimidating, and honestly, its not something everyone is ready to dive into at full speed
Tirzepatide The conversation surrounding retatrutide vs tirzepatide is a sign of a vibrant, rapidly advancing field
Effect of food consumption on the pharmacokinetics, safety, and tolerability of once-daily orally administered orforglipron (LY3502970), a non-peptide GLP-1 receptor agonist